382
Views
16
CrossRef citations to date
0
Altmetric
Original Research

Factors Associated with Non-compliance for Diabetic Retinopathy Follow-up in an Urban Safety-Net Hospital

, , , &
Pages 443-450 | Received 27 Jan 2018, Accepted 18 Jul 2018, Published online: 06 Aug 2018

References

  • Yau J, Rogers SL, Kawasaki R, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35(3):556–564. doi:10.2337/dc11-1909.
  • Sheppler C, Lambert WE, Gardiner SK, Becker TM, Mansberger SL. Predicting adherence to diabetic eye examinations: development of the compliance with annual diabetic eye exams survey. Ophthalmology. 2014;121(6):1212–1219. doi:10.1016/j.ophtha.2013.12.016.
  • Klein R, Knudtson MD, Lee KE, Gangnon R, Klein BE. The Wisconsin Epidemiologic Study of Diabetic Retinopathy: XXII the twenty-five-year progression of retinopathy in persons with type 1 diabetes. Ophthalmology. 2008;115(11):1859–1868. doi:10.1016/j.ophtha.2008.08.023.
  • Schoenfeld E, Greene JM, Wu SY, Leske MC. Patterns of adherence to diabetes vision care guidelines: baseline findings from the diabetic retinopathy awareness program. Ophthalmology. 2001;108:563–571.
  • Paz S, Varma R, Klein R, Wu J, Azen SP. Los Angeles latino eye study group. noncompliance with vision care guidelines in latinos with type 2 diabetes mellitus: the Los Angeles latino eye study. Ophthalmology. 2006;113(8):1372–1377. doi:10.1016/j.ophtha.2006.04.018.
  • Zgibor J, Songer TJ. External barriers to diabetes care: addressing personal and health systems issues. Diabetes Spectrum. 2001;14(1):23–28. doi:10.2337/diaspect.14.1.23.
  • Thompson A, Thompson MO, Young DL, et al. Barriers to follow-up and strategies to improve adherence to appointments for care of chronic eye diseases. Invest Ophthalmol Vis Sci. 2015;56(8):4324–4331. doi:10.1167/iovs.15-16444.
  • Keenum Z, McGwin G, Witherspoon CD, Haller JA, Clark ME, Patients’ OC. Adherence to recommended follow-up eye care after diabetic retinopathy screening in a publicly funded county clinic and factors associated with follow-up eye care use. JAMA Ophthalmol. 2016;134(11):1221–1228. doi:10.1001/jamaophthalmol.2016.3081.
  • Duan F, Liu Y, Chen X, et al. Influencing factors on compliance of timely visits among patients with proliferative diabetic retinopathy in southern China: a qualitative study. BMJ Open. 2017;7(3):1–7. doi:10.1136/bmjopen-2016-013578.
  • Murakami Y, Lee BW, Duncan M, et al. Racial and ethnic disparities in adherence to glaucoma follow-up visits in a county hospital population. Arch Ophthalmol. 2011;129(7):872–878. doi:10.1001/archophthalmol.2011.163.
  • Lee B, Sathyan P, John RK, Singh K, Robin AL. Predictors of and barriers associated with poor follow-up in patients with glaucoma in South India. Arch Ophthalmol. 2008;126(10):1448–1454. doi:10.1001/archopht.126.10.1448.
  • Vengadesan N, Ahmad M, Sindal MD, Sengupta S. Delayed follow-up in patients with diabetic retinopathy in South India: social factors and impact on disease progression. Indian J Ophthalmol. 2017;65(5):376–384. doi:10.4103/ijo.IJO_620_16.
  • Zangalli C, Murchison AP, Hale N, et al. An education- and telephone-based intervention to improve follow-up to vision care in patients with diabetes: a prospective, single-blinded, randomized trial. Am J Med Qual. 2014;31(2):156–161. doi:10.1177/1062860614552670.
  • Mtuya C, Cleland CR, Philippin H, et al. Reasons for poor follow-up of diabetic retinopathy patients after screening in Tanzania: a cross-sectional study. BMC Ophthalmol. 2016;16(115):1–7. doi:10.1186/s12886-015-0180-2.
  • Raman R, Gupta A, Kulothungan V, Sharma T. Prevalence and risk factors of diabetic retinopathy in subjects with suboptimal glycemic, blood pressure and lipid control. Curr Eye Res. 2012;37(6):513–523. doi:10.3109/02713683.2012.669005.
  • Moulton C, Pickup JC, Ismail K. The link between depression and diabetes: the search for shared mechanisms. Lancet Diabetes Endocrinol. 2015;3(6):11. doi:10.1016/S2213-8587(15)00134-5.
  • Gonzalez J, Peyrot M, McCarl LA, et al. Depression and diabetes treatment nonadherence: a meta-analysis. Diabetes Care. 2008;31(12):2398–2403. doi:10.2337/dc08-1341.
  • Chou C, Sherrod CE, Zhang X, et al. Barriers to eye care among people aged 40 years and older with diagnosed diabetes, 2006–2010. Diabetes Care. 2014;37(1):180–188. doi:10.2337/dc13-1507.
  • Chang J, Freed GL, Prosser LA, et al. Comparisons of health care utilization outcomes in children with asthma enrolled in private insurance plans versus medicaid. J Pediatr Health Care. 2014;28(1):71–79. doi:10.1016/j.pedhc.2012.11.001.
  • Tan E, Yang W, Pang B, Dai M, Loh FE, Hogan P. Geographic variation in antidiabetic agent adherence and glycemic control among patients with type 2 diabetes. J Manag Care Spec Pharm. 2015;21(12):1195–1202. doi:10.18553/jmcp.2015.21.12.1195.
  • Storey P, Murchison AP, Pizzi LT, et al. Impact of physician communication on diabetic eye examination: results from a retrospective cohort analysis. Retina. 2016;36(1):20–27. doi:10.1097/IAE.0000000000000652.
  • Lewis K. Improving patient compliance with diabetic retinopathy screening and treatment. Community Eye Health. 2015;28:68–69.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.